Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

by Cristina d’Abramo, Luciano D’Adamio, Luca Giliberto
Published 2020-09-01

Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity.

by Cristina d'Abramo, Christopher M Acker, Heidy T Jimenez, Peter Davies
Published 2013-01-01

Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies.

by Cristina d'Abramo, Christopher M Acker, Heidy Jimenez, Peter Davies
Published 2015-01-01

Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models

by Francesca Vitale, Jasmin Ortolan, Bruce T. Volpe, Philippe Marambaud, Luca Giliberto, Cristina d’Abramo
Published 2020-08-01

Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice

by Francesca Vitale, Luca Giliberto, Santiago Ruiz, Kristen Steslow, Philippe Marambaud, Cristina d’Abramo
Published 2018-08-01

Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo.

by Luca Giliberto, Cristina d'Abramo, Christopher Michael Acker, Peter Davies, Luciano D'Adamio, Luciano D'Adamio
Published 2010-07-01